Patent · US Active

Vaccine for falciparum malaria

US10960065B2 · kind B2 · utility

1Cited by
16References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 22, 2019
Grant dateMar 30, 2021
Priority date—
Expiry dateFeb 22, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for preventing or reducing the severity of malaria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.